UOTTAIMCU
IONS icon

University of Texas/Texas AM Investment Management Co (UTIMCO)’s Ionis Pharmaceuticals IONS Stock Holding History

University of Texas/Texas AM Investment Management Co (UTIMCO)’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$232K Buy
+2,923
New +$220K 0.03% 153

Other funds holding IONS

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.32B AUM 32.9% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

University of Texas/Texas AM Investment Management Co (UTIMCO)'s IONS Position: Q2 2026 in Review

University of Texas/Texas AM Investment Management Co (UTIMCO) opened a new position in Ionis Pharmaceuticals (IONS) in Q2 2026: 2,923 shares worth $232K. The stake represents 0.03% of the portfolio and ranks #153 among its holdings.

322 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • University of Texas/Texas AM Investment Management Co (UTIMCO) held 2,923 shares of Ionis Pharmaceuticals worth $232K as of Q2 2026.
  • Ionis Pharmaceuticals was a new University of Texas/Texas AM Investment Management Co (UTIMCO) position in Q2 2026.
  • Ionis Pharmaceuticals made up 0.03% of University of Texas/Texas AM Investment Management Co (UTIMCO)'s portfolio in Q2 2026, its #153 holding.
  • 322 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q2 2026, filed 3 Aug 2026.